Inventor

LUSKEY KENNETH L

US8 patents

⚠️ This page may combine multiple inventors who share the name “LUSKEY KENNETH L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

METABOLEX INC

5 patents

US6613802B1Sep 2, 2003

Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia

METABOLEX INC98 citations98

US6646004B1Nov 11, 2003

Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia

METABOLEX INC40 citations95

US6624194B1Sep 23, 2003

Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia

METABOLEX INC38 citations92

US7576131B2Aug 18, 2009

Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia

METABOLEX INC12 citations83

US8354448B2Jan 15, 2013

Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes

METABOLEX INC0 citations51

METS OLEX INC

1 patent

US6262118B1Jul 17, 2001

Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes and hyperlipidemia

METS OLEX INC61 citations93

ALESSI THOMAS R

1 patent

US8298561B2Oct 30, 2012

Rapid establishment and/or termination of substantial steady-state drug delivery

ALESSI THOMAS R30 citations91

LUSKEY KENNETH L

1 patent

US8329749B2Dec 11, 2012

Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia

LUSKEY KENNETH L0 citations45